The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis.

Platé, Manuela; Guillotin, Delphine; Chambers, Rachel C

Platé, Manuela; Guillotin, Delphine; Chambers, Rachel C.

Afiliação

Platé M; Centre for Inflammation and Tissue Repair, Dept of Respiratory Medicine, Division of Medicine, University College London, London, UK.
Guillotin D; Centre for Inflammation and Tissue Repair, Dept of Respiratory Medicine, Division of Medicine, University College London, London, UK.
Chambers RC; Centre for Inflammation and Tissue Repair, Dept of Respiratory Medicine, Division of Medicine, University College London, London, UK r.chambers@ucl.ac.uk.

Eur Respir Rev ; 29(157)2020 Sep 30.

Article em En | MEDLINE | ID: mdl-33060168

Assuntos

Fibrose Pulmonar Idiopática; Sirolimo; Matriz Extracelular; Humanos; Fibrose Pulmonar Idiopática/tratamento farmacológico; Pulmão; Serina-Treonina Quinases TOR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sirolimo / Fibrose Pulmonar Idiopática Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google